Ramasamy, Karthik http://orcid.org/0000-0003-3385-3707
Iqbal, Gulnaz
Brouwer, Richard
Stalker, Victoria http://orcid.org/0000-0001-5157-7043
Akhtar, Salma
Varghese, Sherin
Lindsay, Jindriska
Schey, Stephen
Drayson, Mark http://orcid.org/0000-0002-1528-7564
Dunn, Janet
Funding for this research was provided by:
Janssen-Cilag Ltd, Napp and Blood Cancer UK
Article History
Received: 28 July 2022
Revised: 14 November 2022
Accepted: 16 November 2022
First Online: 29 November 2022
Competing interests
: All authors completed the ICMJE disclosure form. The following personal or financial relationships relevant to this manuscript existed during the conduct of the study. KR reports honoraria, research grant from Janssen, Celgene, Takeda, and Amgen. He also reports advisory boards from Celgene, Takeda, Janssen, Amgen, Abbvie, Sanofi, Oncopeptides, Karyopharm, GSK, Adaptive biotech, Pfizer, and speaker’s bureau from Celgene, Takeda and Adaptive Biotech. MD owns shares in Abingdon Health.